Regional Hyperthermia

Targeted Hyperthermia – a powerful chemotherapy and radiation sensitzer for children and adolescents with refractory cancer

Regional hyperthermia, the procedure of raising the temperature of tumor-loaded tissue to 40 - 44°C, is applied as an adjunctive therapy in combination with various established cancer treatments such as chemotherapy and/or radiotherapy. Current research has shown that heat can damage or kill cancer cells in malignant tumors while also making anti-cancer drugs and radiation therapy more effective in treating malignant tumors that are recurrent or progressive despite conventional therapy.

Why to choose the University Hospital of Düsseldorf for solid tumor treatment?

Our experienced team of physicians and researchers have focused on treatment options to finding cures for children, adolescents and adults who suffer from poor prognostic solid tumors such as recurrent germ cell tumors, high-risk soft tissue and bone sarcomas, among others. Our hyperthermia team was the first to develop treatment that proved effective in curing infants and young children with refractory tumors by additional regional hyperthermia. At our clinic a comprehensive team including oncologists, radiation treatment specialists, surgeons, orthopedists and physical therapists, form one of the largest groups dedicated to the treatment of high-risk tumors. The investigators of the University Hospital of Düsseldorf are experts in the treatment of rare but devastating cancers such as germ cell tumor relapses and refractory sarcomas.


PD Dr. med. Rüdiger Wessalowski

Oberarzt der hämatologisch-onkologischen Station sowie des Teil- / Funktionsbereichs regionale Tiefenhyperthermie
Facharzt für Kinder- und Jugendmedizin,Schwerpunkt Kinder-Hämatologie und - Onkologie

Dipl.-Ing. (FH) Oliver Mils

wissenschaftlicher Mitarbeiter (Arbeitsgebiet: regionale Tiefenhyperthermie)

MediathekInformation und Wissen
LageplanSo finden Sie uns